Hormone Therapy for Postmenopausal Women with Urinary Incontinence
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence. Hormone therapy is associated with worsening urinary incontinence in postmenopausal women who are incontinent at baseline (Strength of Recommendation [SOR]: A, based on a systematic review) and is associated with an increased risk of developing urinary incontinence in those who are continent at baseline (SOR: A, based on two large randomized controlled trials [RCTs]).
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.